Today: 1 May 2026
WiseTech Global stock slides 4.7%: AI job cuts, CEO buy and dividend dates now in focus

WiseTech Global stock slides 4.7%: AI job cuts, CEO buy and dividend dates now in focus

SYDNEY, March 2, 2026, 18:28 AEDT — Market closed

Shares of WiseTech Global Ltd fell 4.7% on Monday to A$45.29, after swinging between A$43.90 and A$46.09 in the session.

The pullback lands as investors try to work out what WiseTech’s AI push means in practice — fewer people, faster code, and whether service levels hold up while the company is still digesting a big acquisition.

WiseTech last week flagged about 2,000 job cuts as part of an AI-led overhaul, with CEO Zubin Appoo arguing “the era of manually writing code as the core act of engineering is over.” Shares jumped 11.1% that day, but the stock remained 68% below its November 2024 peak; Marc Jocum, senior product and investment strategist at Global X ETFs, said the recent weakness was “more governance-driven than fundamental.” Reuters

Broader markets were steady, but tech lagged. The S&P/ASX 200 closed up 0.03% while the All Tech index fell 2.52% and the information technology sector slid 3.07% as weekend escalation around Iran pushed investors toward energy and other defensives.

In its half-year results release, WiseTech reported total revenue of $672.0 million in the six months to Dec. 31, with underlying net profit after tax of $114.5 million and statutory net profit of $68.1 million. It reaffirmed FY26 guidance for revenue of $1.39 billion–$1.44 billion and EBITDA — earnings before interest, tax, depreciation and amortisation, a common cash-earnings yardstick — of $550 million–$585 million.

A separate filing late last week showed Appoo bought 20,020 WiseTech shares for a total A$1,000,049.19, purchased on-market on Feb. 26 and expected to settle on March 2.

The workforce plan has also drawn scrutiny from labour groups. Professionals Australia, a union representing tech and engineering workers, sought an urgent meeting with WiseTech and said “the introduction of AI on this scale is clearly a major workplace change.” Reuters

For now, the debate in the market is less about this week’s numbers and more about execution. Investors want signs the company can take costs out without choking product delivery or customer support, and without dragging the e2open integration back into the headlines.

But it can still go wrong. Restructuring can cost money upfront, timelines can slip, and staff pushback can slow changes — and any hit to global trade volumes would test a business built on transactions moving through logistics and supply-chain systems.

Next up is the interim dividend timetable. WiseTech’s shares go ex-dividend on March 13 — meaning buyers from that date do not get the upcoming payout — with a March 16 record date and an April 10 payment date, according to an ASX notice.

Stock Market Today

  • Seaport Therapeutics Upsizes IPO to $255M, CEO Highlights New Biotech Pathway
    May 1, 2026, 2:02 PM EDT. Seaport Therapeutics raised $254.9 million in an upsized Nasdaq IPO, exceeding initial $180 million estimates. CEO Daphne Zohar highlighted a shift from traditional M&A (mergers and acquisitions) to public offerings, reflecting confidence in developing and marketing their depression drug pipeline independently. The company may raise an additional $38.2 million through underwriters' option. Zohar pointed to industry changes where biotech firms are now focusing on advancing medicines directly to patients, citing success stories like Karuna Therapeutics and Intra-Cellular Therapies. Seaport's board recently welcomed Sharon Mates, who led Intra-Cellular to a $1.5 billion drug launch before its J&J acquisition. This IPO signals renewals in the biotech public market despite recent Big Pharma dealmaking.

Latest article

Dow Jones Today: Why the Blue-Chip Rally Stalled as Apple, S&P 500 and Nasdaq Pushed Higher

Dow Jones Today: Why the Blue-Chip Rally Stalled as Apple, S&P 500 and Nasdaq Pushed Higher

1 May 2026
The Dow Jones Industrial Average fell 78.72 points to 49,573.42 by midday Friday, reversing an early rally as tariff concerns weighed on gains from Apple and other strong earnings reports. President Donald Trump announced a 25% tariff on EU-made cars and trucks starting next week. Apple reported quarterly revenue of $111.2 billion, up 17% year over year. Oil prices dropped after Iran sent a new negotiation proposal.
US Stock Market Today: Why the S&P 500 and Nasdaq Are Hitting Fresh Highs

US Stock Market Today: Why the S&P 500 and Nasdaq Are Hitting Fresh Highs

1 May 2026
The S&P 500 rose 0.48% and the Nasdaq 0.96% to record highs Friday, while the Dow slipped 0.11%. Apple shares climbed after reporting its strongest quarterly sales growth in over four years. Atlassian and other software stocks rallied on strong cloud demand. Exxon and Chevron beat profit estimates but cited pressure from Middle East conflict and volatile oil prices.
Recursion Pharmaceuticals Stock: Founder Chris Gibson to Leave Board as RXRX Nears Q1 Earnings

Recursion Pharmaceuticals Stock: Founder Chris Gibson to Leave Board as RXRX Nears Q1 Earnings

1 May 2026
Recursion Pharmaceuticals said founder and board chair Chris Gibson will not seek re-election at the June 17 annual meeting, months after stepping down as CEO. The company reports first-quarter results May 6, with investors watching for updates on cash, clinical progress, and its AI drug platform. Recursion last reported $753.9 million in cash and narrowed its quarterly net loss. Gibson will remain chair until his term ends.
Qantas share price slides on Iran conflict and oil spike — what investors watch next
Previous Story

Qantas share price slides on Iran conflict and oil spike — what investors watch next

Ashtead share price: AHT set to disappear from London screens as Sunbelt listing goes live
Next Story

Ashtead share price: AHT set to disappear from London screens as Sunbelt listing goes live

Go toTop